465 filings
Page 8 of 24
424B5
SIOX
Sio Gene Therapies Inc.
21 Feb 20
Prospectus supplement for primary offering
12:00am
3
Eric Venker
19 Feb 20
Axovant Gene Therapies / Eric Venker ownership change
5:35pm
424B5
SIOX
Sio Gene Therapies Inc.
19 Feb 20
Prospectus supplement for primary offering
5:28pm
PRE 14C
SIOX
Sio Gene Therapies Inc.
19 Feb 20
Preliminary information
7:32am
8-K
SIOX
Sio Gene Therapies Inc.
19 Feb 20
Departure of Directors or Certain Officers
6:01am
SC 13G/A
SIOX
Sio Gene Therapies Inc.
13 Feb 20
Beneficial ownership report (amended)
12:43pm
SC 13G/A
SIOX
Sio Gene Therapies Inc.
11 Feb 20
Beneficial ownership report (amended)
12:16pm
8-K
SIOX
Sio Gene Therapies Inc.
10 Feb 20
Results of Operations and Financial Condition
6:05am
10-Q
2020 Q3
SIOX
Sio Gene Therapies Inc.
Quarterly report
10 Feb 20
6:04am
UPLOAD
SIOX
Sio Gene Therapies Inc.
16 Jan 20
Letter from SEC
12:00am
8-K
SIOX
Sio Gene Therapies Inc.
13 Jan 20
Regulation FD Disclosure
6:43am
S-3
SIOX
Sio Gene Therapies Inc.
Shelf registration
10 Jan 20
5:10pm
SC 13D/A
ROIV
Roivant Sciences Ltd
31 Dec 19
Axovant Gene Therapies Ltd.
4:45pm
8-K
SIOX
Sio Gene Therapies Inc.
3 Dec 19
Axovant Announces Amendment to Credit Facility with Hercules Capital
7:19am
8-K
SIOX
Sio Gene Therapies Inc.
8 Nov 19
Departure of Directors or Certain Officers
4:53pm
8-K
SIOX
Sio Gene Therapies Inc.
8 Nov 19
Results of Operations and Financial Condition
8:03am
10-Q
2019 Q2
SIOX
Sio Gene Therapies Inc.
Quarterly report
8 Nov 19
8:02am
8-K
SIOX
Sio Gene Therapies Inc.
23 Oct 19
Axovant Presents First Evidence of Clinical Stabilization in Tay-Sachs Disease at the European Society of Gene and Cell Therapy 27th Annual Congress
7:03am
4
Corcoran Gavin
24 Sep 19
Axovant Gene Therapies / Gavin Corcoran ownership change
5:15pm
4
Nassif David W.
24 Sep 19
Axovant Gene Therapies / David W. Nassif ownership change
5:15pm